GlobeImmune, Inc.
$15 M
IPO
Sole Book-Runner
Garnero Group Acquisition Company
$125 M
IPO
Co-Manager
CollabRx, Inc.
$1.8 M
Secondary/Follow-On
Sole Book-Runner
China Biologic Products, Inc.
$58.9 M
Secondary/Follow-On
Co-Manager
Signal Genetics, Inc.
$8.5 M
IPO
Sole Book-Runner
1347 Property Insurance Holdings, Inc.
$23 M
Secondary/Follow-On
Sole Book-Runner
Top Ships, Inc.
$21.3 M
Secondary/Follow-On
Sole Book-Runner
Corbus Pharmaceuticals Holdings, Inc
$10.3 M
Private Placement
Sorrento Therapeutics, Inc.
$28.8 M
Secondary/Follow-On
Sole Book-Runner
InVivo Therapeutics Holdings Corp.
$16.1 M
Secondary/Follow-On
Sole Book-Runner
San Luis Facility Development Corporation
$26.1 M
New Issue
Aldeyra Therapeutics, Inc.
$12 M
IPO
Sole Book-Runner